Table 1 Demographic information for males and females by allelic classes
From: Intellectual functioning and behavioural features associated with mosaicism in fragile X syndrome
| Â | Males | Females | Males vs. females | ||||
|---|---|---|---|---|---|---|---|
FM-only (n = 70) (%) | PM/FM mosaic (n = 20) (%) | p | FM-only (n = 28)a (%) | PM/FM mosaic (n = 8) (%) | p | p | |
Seizuresb | 13.0 | 5.6 | 0.680 | 3.7 | 0.0 | 0.999 | 0.175 |
Medication | |||||||
 Medicated | 44.3 | 30.0 | 0.309 | 25.9 | 0.0 | 0.166 | 0.036 |
 Stimulant | 20.0 | 10.0 | 0.508 | 7.4 | 0.0 | 0.999 | 0.097 |
 SSRI | 21.4 | 5.0 | 0.109 | 11.1 | 0.0 | 0.999 | 0.271 |
 SNRI | 0.0 | 5.0 | 0.222 | 3.7 | 0.0 | 0.999 | 0.483 |
 Benzodiazepines | 0.0 | 5.0 | 0.222 | 0.0 | 0.0 | - | 0.999 |
 Anti-psychotic | 11.4 | 10.0 | 0.999 | 3.7 | 0.0 | 0.999 | 0.180 |
 Anticonvulsant | 7.1 | 5.0 | 0.999 | 3.7 | 0.0 | 0.999 | 0.672 |
 Adrenergic alpha agonist | 4.3 | 5.0 | 0.999 | 3.7 | 0.0 | 0.999 | 0.999 |
 Melatonin | 8.6 | 0.0 | 0.333 | 0.0 | 0.0 | 0.999 | 0.184 |
Ethnicityc | |||||||
 Australian/European | 36.2 | 55.0 | 0.407 | 66.7 | 50.0 | 0.219 | 0.076 |
 Mestizo | 46.4 | 35.0 |  | 18.5 | 50.0 |  |  |
 Other* | 17.4 | 10.0 |  | 14.8 | 0.0 |  |  |